Thyroid and Adrenal Disorders in ICU
1 other identifier
observational
200
1 country
1
Brief Summary
A dysregulated host response to infection results in organ failure and sepsis, a potentially fatal illness. Sepsis killed about 11 million people worldwide in 2017 and had a death rate close to 20 %
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2025
CompletedFirst Posted
Study publicly available on registry
November 24, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
November 24, 2025
November 1, 2025
1 year
September 26, 2025
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
serum Thyroid and adrenal hormones levels
measurement of thyroid and adrenal hormones (TSH-FT3-FT4 - cortisol level ) will be measured by ELLISA technique in septic shock patients at ICU.
24 hours
Study Arms (1)
Patients with septic shock in the ICU
Blood sampling for thyroid and adrenal hormones
Interventions
Eligibility Criteria
Patients with septic shock admitted at intensive care unit and their age is above 18 years old
You may qualify if:
- All Patients who match the diagnostic criteria for sepsis/septic shock as stated
- admitted in ICU
You may not qualify if:
- Patients refuse to be enrolled in the study
- Patients with previous endocrinal disorders.
- Patients receiving corticosteroid or thyroid hormonal therapy.
- Pregnancy or lactation.
- Previous endocrinal gland surgery.
- Individuals with pacing rhythms, bundle branch blocks (QRS interval \>120 ms),
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Radwa mahmoud
Asyut, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Radwa m elsayed, MB
assuit university hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
September 26, 2025
First Posted
November 24, 2025
Study Start
December 1, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
November 24, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share